Smart Inhalers
$0.00 bnAnnual import
20%Indian capability
4,988Supplier concentration (HHI)
₹1,289 crTo localise
Why India imports it. Reasoned estimate: India has limited domestic capacity for smart inhalers; sector trade patterns indicate continued import reliance.
Why it matters. Strategic dependency within medical devices value chain; affects downstream manufacturing competitiveness.
Can India localise it? Hard
Where it comes from. UK (58%), China (32%), USA (10%).
Scorecard
The ten indices
CMDI 64.82Dependency
LPI 47.5Localisation potential
IAI 59.75Investment attractiveness
SRI 65.74Supply risk
SCI 56Supply-chain complexity
TRI 40.5Technology readiness
IMI 67Industrial multiplier
NSRI 56.5National-security relevance
EPI 59.5Export potential
ICGI 67.8Capability gap
Intelligence
Related signals
Sources
Primary references
Confidence: Reasoned estimate. Reasoned estimate derived from sector trade patterns and HS code classification; specific company/number values are modelled. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).